✦ LIBER ✦

Multilineage dysplasia is associated with a poorer prognosis in patients with de novo acute myeloid leukemia with intermediate-risk cytogenetics and wild-typeNPM1

✍ Scribed by Rozman, María; Navarro, José-Tomás; Arenillas, Leonor; Aventín, Anna; Giménez, Teresa; Alonso, Esther; Perea, Granada; Camós, Mireia; Navarrete, Mayda; Tuset, Esperanza; Florensa, Lourdes; Millá, Fuensanta; Nomdedéu, Josep; de la Banda, Esmeralda; Díaz-Beyá, Marina; Pratcorona, Marta; Garrido, Ana; Navarro, Blanca; Brunet, Salut; Sierra, Jorge; Esteve, Jordi

Book ID: 125344192
Publisher: Springer
Year: 2014
Tongue: English
Weight: 350 KB
Volume: 93
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-014-2100-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TET2 mutation is an unfavorable prognost

TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics

✍ Chou, W.-C.; Chou, S.-C.; Liu, C.-Y.; Chen, C.-Y.; Hou, H.-A.; Kuo, Y.-Y.; Lee, 📂 Article 📅 2011 🏛 American Society of Hematology 🌐 English ⚖ 428 KB

De novo acute myeloid leukemia with mult

De novo acute myeloid leukemia with multilineage dysplasia: treatment results and prognostic evaluation from a series of 44 patients treated with fludarabine, cytarabine and G-CSF (FLAG)

✍ Felicetto Ferrara; Salvatore Palmieri; Barbara Pocali; Filiberto Pollio; Assunta 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

CEBPA single mutation can be a possible

CEBPA single mutation can be a possible favorable prognostic indicator in NPM1 and FLT3-ITD wild-type acute myeloid leukemia patients with intermediate cytogenetic risk

✍ Park, Sang Hyuk; Chi, Hyun-Sook; Cho, Young-Uk; Jang, Seongsoo; Park, Chan-Jeoun 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 758 KB

TP53 gene mutation is frequent in patien

TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis

✍ Bowen, D; Groves, M J; Burnett, A K; Patel, Y; Allen, C; Green, C; Gale, R E; Hi 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 170 KB

Improved outcome of patients with low- a

Improved outcome of patients with low- and intermediate-risk cytogenetics acute myeloid leukemia (AML) in first relapse with gemtuzumab and cytarabine versus cytarabine : Results of a retrospective comparative study

✍ Thomas Prebet; Anne Etienne; Raynier Devillier; Emilie Romeo; Aude Charbonnier; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 1 views

A scoring system to predict the risk of

A scoring system to predict the risk of death during induction with anthracycline plus cytarabine-based chemotherapy in patients with de novo acute myeloid leukemia

✍ David Valcárcel; Pau Montesinos; Isabel Sánchez-Ortega; Salut Brunet; Jordi Este 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB 👁 2 views

## Abstract ## BACKGROUND: A prognostic index to predict induction death in adult patients receiving induction chemotherapy for de novo acute myeloid leukemia (AML) was developed. ## METHODS: The authors analyzed 570 patients (aged 16‐70 years) included in 2 multicenter trials of the CETLAM Grou